celecoxib has been researched along with Thromboembolism in 9 studies
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| " cerebral infarction, myocardial infarction and unstable angina pectoris, among rofecoxib and naproxen users in comparison to diclofenac users." | 3.76 | Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. ( Einarsdottir, R; Gudbjornsson, B; Halldorsson, M; Johannsson, M; Sigvaldason, H; Thorgeirsson, G; Thorsteinsson, SB; Zoega, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudbjornsson, B | 1 |
| Thorsteinsson, SB | 1 |
| Sigvaldason, H | 1 |
| Einarsdottir, R | 1 |
| Johannsson, M | 1 |
| Zoega, H | 1 |
| Halldorsson, M | 1 |
| Thorgeirsson, G | 1 |
| Layton, D | 3 |
| Hughes, K | 1 |
| Harris, S | 2 |
| Shakir, SA | 3 |
| Clark, DW | 1 |
| Kasliwal, R | 1 |
| Wilton, L | 1 |
| Mathieu, C | 1 |
| Meier, P | 1 |
| Meyer zu Starten, A | 1 |
| Burnier, M | 1 |
| DuBois, RN | 1 |
| Heim, HK | 1 |
| Broich, K | 1 |
| Lee, YH | 1 |
| Ji, JD | 1 |
| Song, GG | 1 |
| Patrono, C | 1 |
| Patrignani, P | 1 |
| García Rodríguez, LA | 1 |
3 reviews available for celecoxib and Thromboembolism
| Article | Year |
|---|---|
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzy | 2004 |
[Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibi | 2005 |
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Blood Platelets; Cardiova | 2001 |
1 trial available for celecoxib and Thromboembolism
| Article | Year |
|---|---|
Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk.
Topics: Adenoma; Adenomatous Polyps; Angina, Unstable; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactone | 2007 |
5 other studies available for celecoxib and Thromboembolism
| Article | Year |
|---|---|
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.
Topics: Angina, Unstable; Celecoxib; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Databases, Factual; D | 2010 |
Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cele | 2003 |
A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Lactones; Product Surveilla | 2005 |
The COX-2 story: is any drug completely "safe?".
Topics: Celecoxib; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Humans; Prod | 2006 |
Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspects.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; | 2006 |